Genetic Disorder L.P. Kkr's Net Worth
Genetic Disorder L.P. Kkr's net worth is estimated to be at least $677,114,649.10 as of 11/23/2024. CoreStreet's estimation of Genetic Disorder L.P. Kkr's net worth is based on their sale of stock and current holding of stock.
Genetic Disorder L.P. Kkr is Major Shareholder at BridgeBio Pharma Inc. They have executed at least 6 trades of stock as per SEC Form 4 filings. Their most recent trade was for 5,800,000 units of BBIO stock on 09/13/2024. Their biggest sale was on 02/17/2021 when they sold 3,450,000 units of BridgeBio Pharma Inc stock for $208,621,500.00. They typically trade 1 times per year.
Total value of insider buys:
- $90,001,400.00
Total value of insider sells:
- $587,113,249.10
Most recent insider trade:
- Sept. 13, 2024
Genetic Disorder L.P. Kkr's Insider Trading History
| BridgeBio Pharma Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 13, 2024 | Major Shareholder | 5,800,000 | $25.75 | Sell | $149,350,000.00 |
Feb. 17, 2021 | Major Shareholder | 3,450,000 | $60.47 | Sell | $208,621,500.00 |
May 28, 2020 | Major Shareholder | 2,389,690 | $33.39 | Sell | $79,791,749.10 |
July 1, 2019 | Major Shareholder | 2,647,100 | $17.00 | Buy | $45,000,700.00 |
| KKR & Co LP | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 13, 2024 | Major Shareholder | 5,800,000 | $25.75 | Sell | $149,350,000.00 |
July 1, 2019 | Major Shareholder | 2,647,100 | $17.00 | Buy | $45,000,700.00 |